Posts by Danielle Eaton
AAHP Updates Rep. Curtis on Homeopathic Industry Issues
On Sept. 16, 2022, AAHP once again sat down with U.S. Congressman John Curtis (R-Utah-3rd district) to brief him on the homeopathic industry and AAHP’s current work with the U.S.…
Read MoreNewly Revised FDA Inspection Guidance Document
By Eric Foxman, AAHP Secretary, Pharm. (Ret.) The U.S. Food and Drug Administration released a revised Inspection Guidance for its staff. While the overall contents are not new, it is…
Read MorePharmacy Spotlight: Anthony Qaiyum of Merz Apothecary
What are consumers looking for from homeopathy today? As manufacturers, how can we best serve them? An excellent way to get a pulse on our consumers is to look to…
Read MoreCreating Awareness for and Protecting Homeopathic Products
By Mark Land, AAHP President People imagine “Public Affairs” as meaning fancy-suited lobbyists manipulating legislators in ways that don’t benefit the public. This oversimplifies the process and is demeaning to…
Read MoreA Quick Look Back: 100 Years of AAHP
By Eric Foxman, Pharm. (Ret.), AAHP Secretary A hundred years ago the homeopathic industry was, not surprisingly, vastly different. There was no industrial production, and little marketing to consumers. A…
Read MoreRetail is Alive and Well
By Mark Land, AAHP President Retailers represent a strong touchpoint within a community, providing goods and services in a way that promotes stability, accessibility to products, and more. The “more”…
Read MoreWhat is the Future of Retail?
By Ray Petrick What was old is now new, or maybe not as new as we think. If you’re a baby boomer you probably remember that home delivery was commonplace…
Read MoreH-E-B to Receive AAHP Integrative Medicine Award
MILWAUKIE, Ore., Oct. 19, 2022 —The American Association of Homeopathic Pharmacists (AAHP) has named H-E-B as the 2022 recipient of their Integrative Medicine Retailer Award. This honor recognizes a retailer…
Read MoreHouse and Senate Advance FDA User Fee Reauthorization Bills
By Pete Evich In the month of June, both the House and Senate advanced separate pieces of legislation that reauthorize FDA’s prescription drug, medical device, biosimilars, and generic drug user…
Read MoreThe Legal Status of the HPUS as an Official Compendium
By Al Lorman, AAHP Counsel Pharmacopoeias have been around for thousands of years. Historically, they provided the medical community with critical information necessary to make (and sometimes use) drugs. In…
Read More